API
< Back to situations

[ORGANIZATION]

Dr Reddy’s Laboratories

Featured in 2 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [BR] [ES] [IN]

Semaglutide market developments in Brazil and Spain

2 clusters · 2 sources · last updated

Latest: Novo Nordisk launches 2 mg Ozempic dose in Spain

Developments regarding semaglutide treatments have emerged in Brazil and Spain. In Brazil, Dr Reddy’s Laboratories secured marketing authorization from the National Health Surveillance Agency (ANVISA) to sell a generic v